Sign in / Join Now
ETFs & Funds
with continued high short interest. Of all the stocks to short, this is one of the worst. Solid data. Potential to go up 10x quickly
i like where your heads at ...i would like to see the chart mirror that of
Th-302 could be the breakthru drug that oncologists have been looking for. By targeting hypoxic niche, kills CSCs that promotes recurrence
Hypoxic CSCs r the 'untouchables' in oncology. Must b killed, but cannot get to them.
Add a reply...
Latest StockTalks »
people get THLD breaking news and analysis by email alert.
Get email alerts on THLD »
Threshold Pharmaceuticals, Inc.
Get latest price
From other sites
Threshold Pharmaceuticals And National Cancer Institute To Collaborate On Drug Candidate TH-3424
at TheStreet (Dec 19, 2016)
Threshold Pharmaceuticals Announces Presentation And Webcast At The Stifel Healthcare Conference 2016
at TheStreet (Nov 15, 2016)
Threshold Pharmaceuticals Reports Third Quarter Financial Results
at TheStreet (Nov 7, 2016)
Caris Life Sciences And Threshold Pharmaceuticals Collaborate To Utilize Caris' ADAPT Biotargeting System In The Development Program For Evofosfamide
at TheStreet (Oct 25, 2016)
Is Threshold Pharmaceuticals a Buy? (THLD)
at Investopedia (Oct 3, 2016)